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Abstract
Group A Streptococcus (GAS) infections remain a significant health care problem due to high morbidity and mortality
associated with GAS diseases, along with their increasing worldwide prevalence. Macrophages play a key role in the control
and clearance of GAS infections. Moreover, pro-inflammatory cytokines production and GAS persistence and invasion are
related. In this study we investigated the correlation between the GAS clinical isolates genotypes, their known clinical
history, and their ability to modulate innate immune response. We constituted a collection of 40 independent GAS isolates
representative of the emm types currently prevalent in France and responsible for invasive (57.5%) and non-invasive (42.5%)
clinical manifestations. We tested phagocytosis and survival in mouse bone marrow-derived macrophages and quantified
the pro-inflammatory mediators (IL-6, TNF-a) and type I interferon (INF-b) production. Invasive emm89 isolates were more
phagocytosed than their non-invasive counterparts, and emm89 isolates more than the other isolates. Regarding the
survival, differences were observed depending on the isolate emm type, but not between invasive and non-invasive isolates
within the same emm type. The level of inflammatory mediators produced was also emm type-dependent and mostly
invasiveness status independent. Isolates of the emm1 type were able to induce the highest levels of both pro-inflammatory
cytokines, whereas emm89 isolates induced the earliest production of IFN-b. Finally, even within emm types, there was a
variability of the innate immune responses induced, but survival and inflammatory mediator production were not linked.
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Introduction
Group A Streptococcus (GAS, Streptococcus pyogenes) is among the
most ubiquitous and versatile human bacterial pathogen with
major healthcare and economic impacts [1,2]. This Gram-positive
bacterium can cause a broad range of diseases, from self-limiting
suppurative infection of the upper respiratory tract (pharyngitis)
and skin (impetigo) to deeper and life threatening invasive
infections such as toxic shock-like syndrome (STSS), necrotizing
fasciitis (NF), with an estimated 500,000 deaths yearly [1,2].
Since the late 1980’s a marked increase of GAS invasive
infections has been reported world-wide [1]. Traditionally, GAS
have been classified into serological types using M protein
serotyping and T protein agglutination assays. Currently, the
most widely used typing-method for GAS strains relies on the
59end of the emm gene sequence that encodes the hypervariable
amino-terminus region of the M protein [3]. To date more than
200 different emm gene types have been defined [4] and the most
prevalant emm types associated with invasive infections in Europe
are emm1, emm28 and emm89, with variable distribution worldwide
[5,6]. While correlation between emm types and tissue tropism has
been reported no link with disease severity has been highlighted
except for emm1 and emm3 strains, that are associated with NF and
STSS [6,7].
GAS has been described as an extracellular bacterium that
circumvent the host immune defenses to survive and persist. It has
indeed evolved a broad array of virulence factors to outwit the
activities of phagocytic cells [8,9] and it has developed a number of
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strategies to avoid or induce an overeaction of the host immune
system. Surface components of GAS including a family of M-
proteins, the hyaluronic acid capsule, fibronectin and collagen-
binding proteins allow the microorganism to adhere, colonise and
invade human skin and mucosal tissues under different environ-
mental conditions [2]. The M protein, a fimbrial surface protein, is
highly variable and grouped in three classes A-C, D, E [10]. It has
an anti-phagocytic activity and it binds to diverse host molecules
depending on the class it belongs to among which complement
proteins that prevent the alternative complement pathway
activation. The bacterium thus evades killing by the polymorpho-
nuclear leucocytes [8,11]. The hyaluronic acid capsule confers
invasiveness in vivo through the resistance to phagocytosis by
interfering with binding of antibodies [12]. GAS also secretes
virulence factors. The SpeB cysteine protease is a crucial virulence
factor, wich is able to modulate GAS surface proteins function in
colonization and significantly contibutes to tissue destruction in
necroziting fasciitis. SpeB can cleave host extracellular matrix
proteins, as well as immune system components, and activate
matrix metalloproteinases to promote further tissue damage and
the release of proapoptotic factors [13]. SLO is a human-specific
cytolysin with a range of properties, including the ability to form
pores and to prevent the internalization of GAS by lysosomes, thus
enhancing the intracellular survival of GAS within epithelial cells
[14]. The streptococcal pyrogenic exotoxins (SpeA, SpeC, SpeG to
SpeM), streptococcal superantigen A (SSA), and streptococcal
mitogenic exotoxin Z (SmeZ) have been identified as superanti-
gens; they are released as toxins that can activate a large
proportion of T-cell population, eliciting inflammatory response
[2,15]. The excessive uncoordinate release of cytokines such as IL-
1, IL-2, IL-6, TNF-a, IFN, overrides the body, resulting in rash,
fever, organ failure, coma and death. Epidemiological studies have
tentatively searched for links between emm types, superantigen
profiles and strain invasiveness but they report different conclu-
sions [16,17].
The primary line of innate immune defense against most
bacterial pathogens consists of resident macrophages and poly-
morphonuclear neutrophils (PMN’s). It has been demonstrated
that macrophages have a profound influence in the early host
immune defense against GAS [18,19]. Yet, their role in the early
steps of GAS infection remains unclear as they can kill GAS or, in
opposite, promote their intracellular survival and even growth.
The high variability of the clinical manifestations is due on the
one hand to the diversity of the GAS strains and the other hand to
the influence of the host immunogenetic background [2,20,21].
Nevertheless, there are no studies addressing whether, and if so
how, GAS diversity contributes to differential or even opposite
response of the innate immune system. In the present study, we
searched whether GAS clinical isolates of distinct genotypes have a
differential ability to modulate bone marrow-derived macrophages
(BMDMs) response and whether this property correlates with the
GAS repertoire of pathologies. For this purpose, we selected a
collection of independent invasive and non-invasive clinical
isolates representative of the most prevalent emm types circulating
in France and analyzed in vitro how they interact with BMDMs.
Criteria of study include bacteria phagocytosis, bacterial survival
and the cell cytokine response profile with a specific screen for pro-
inflammatory (IL-6 and TNF-a) and immunomodulatory (IFN-b)
cytokines.
Our findings demonstrate that innate immune response elicited
by Group A Streptococcus is highly variable among clinical
isolates and correlates with the emm type.
Material and Methods
Characterization of GAS isolates
GAS clinical isolates were collected by the CNR-Strep (Table
S1) (https://cnr-strep.fr/). The invasive status was defined as the
isolation of bacteria from a usually sterile site (e.g. blood,
cerebrospinal fluid, bone or joint fluid), or from samples obtained
from a non-sterile site in combination with clinical signs of
necrotizing fasciitis (NF) or streptococcal toxic shock syndrome
(STSS). Bacteraemia was considered to be without focus when no
focal symptoms could be identified. Colonization isolates were
obtained from pharyngeal carrier obtained from random cases
with no clinical symptoms associated. emm sequence type was
determined by sequencing the variable 59-end of the emm gene and
comparing sequences with database of the Center for Disease
Control and Prevention [3] (http://www.cdc.gov/ncdidod/
biotech/strep/doc.htm). PCR reactions were performed to detect
the presence of toxin or superantigen genes or alleles, speA 1-5,
speB, speC, speJ and ssa as described [6,22]. The emm1 invasive
strain ATCC 700294 was used as a control [23].
Bacterial growth conditions
GAS isolates were grown at 37uC without agitation in Todd-
Hewitt broth (THB) or in DMEM medium at 37uC under 5%
CO2 atmosphere. Bacteria were collected in mid-log phase,
washed twice with sterile phosphate-buffered saline (PBS), and
diluted to the required inoculum and the number of viable
bacteria was determined by counting the colony forming units
(CFUs) after plating dilutions on TH agar (THA).
Macrophage cultures and infection assays
Primary bone marrow-derived macrophages (BMDMs) from 6-
10 weeks-old female C57Bl/6 mice (Charles River Laboratories),
were cultivated in DMEM supplemented with 10% fetal calf
serum in the presence of GM-CSF (10 ng/mL) and antibiotics,
30 U/mL penicillin and 30 mg/mL streptomycin as previously
described [23]. After 10 days, twenty-four well plates were seeded
with 56105 BMDM’s per well and 24 hours later, mid-logarithmic
phase bacterial cultures were added at a multiplicity of infection
(MOI) of 100 [23]. After 30 min of incubation at 37uC and 5%
CO2, the non-adherent extracellular bacteria were eliminated
removing the culture medium and three washing with sterile PBS.
The adherent extracellular bacteria were subsequently killed by
incubation, with fresh medium containing 30 U/mL penicillin/
and 30 mg/mL streptomycin. At time 0 (T0 which corresponded
to 30 min after addition of antibiotics) and at specific time points
after, supernatants were collected, centrifuged at 10,000 rpm at
4uC and frozen at 220uC for cytokine quantification and
macrophages were lysed with 1 mL sterile distilled water. Serial
dilutions of cellular lysates were plated on THA plates and the
number of CFUs was determined after 24–48 hours growth at
37uC. For all experiments, 3 independent assays in triplicate were
carried out for each bacterial isolate.
Neutral red uptake assay
The neutral red (NR) uptake assay provides a quantitative
estimation of the number of viable cells in a culture [24]. Briefly,
after infection cells were washed with warm PBS and 500 mL of
NR-medium solution (40 mg/mL in DMEM medium) was added
and the cells were further incubated at 37uC, 5% CO2 for 2 hours.
The NR-medium solution was then removed; cells were washed
with PBS and 250 ml neutral red de-staining solution (acetic acid
1%/ethanol 50%) was added. The plates were rapidly shaken until
the neutral red had been extracted from the cells and had formed
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a homogeneous solution. The OD of neutral red extract was
measured at 540 nm in a microtiter plate reader spectrophotom-
eter.
Cytokine quantification
The levels of IL-6, TNF-a and IFN-b were determined, by
ELISA, in the supernatants of GAS infected, LPS-stimulated
(10 mg/mL, positive control) and unstimulated (negative control)
BMDMs. IL-6 and TNF-a were assayed using DuoSet ELISA kits
(R&D Systems, Minneapolis, MN). The amount of IFN-b was
measured using VeriKine Mouse Interferon Beta Kit (PBL
Biomedical laboratories), according to manufacturers’ instructions.
For all experiments, three independent assays in triplicate were
carried out for each bacterial isolate.
Statistical analysis
Data were analyzed using GraphPad Prism 5.0 (GraphPad
Software, San Diego, California). The significance of differences
between the values was determined by Mann-Withney test.
Significance levels were set at *p#0.05; **p#0.01; ***p#0.005.
Ethics statement
All of the animal experiments described in this study were
conducted in accordance with guidelines of Cochin Institute, in
compliance with the European animal welfare regulation (http://ec.
europa.eu/environment/chemicals/lab_animals/home_en.html) and
were approved by the Institut Cochin animal care and use committee.
Results
Selection and genotypic characterization of a relevant
collection of GAS clinical isolates
To maximize the relevance of isolate sampling, we selected from
the CNR-Strep collection 40 non-redundant GAS isolated from i)
different geographical areas, ii) at different time periods, iii)
humans of different ages, and iv) responsible for invasive with or
without STSS (Inv; n = 23) and non-invasive (pharyngitis, cutane-
ous infections) infections (NInv; n = 17) (Table S1). These GAS
isolates belonged to the emm1 (n = 15), emm28 (n = 13) and emm89
(n = 12) that are the most prevalent emm types circulating in
France, but also in other European countries and Northern
America (Table S1).
We determined the toxin gene profile of these isolates by PCR
(Table S1) and found it to be comparable to those described in
epidemiological studies [6,17,25]. As expected, the speB gene was
detected in all GAS isolates whatever the emm type. All emm1
isolates contained speA and speJ. speA1–3 alleles were found in all
emm1 isolates, with the exception of the M1 NInv1 isolate which
harbors the speA5 allele. Among the 40 isolates, those from the
emm1 group are the only ones to display such uniformity for these
two toxin genes and which is invasiveness status independent.
Furthermore, isolates M1 Inv7, M1 Inv8 and M1 NInv5 also
harbor speC. All emm28 isolates carry the speC gene and half of
them, equally distributed among the invasive and non-invasive
isolates, also harbor speJ. The emm89 isolates had, with the
exception of M89 Inv2, M89 Inv5 and M89 NInv2, speC, equally
distributed among invasive and non-invasive isolates. These results
confirmed that the toxin gene profile is quite similar within each
emm type, but differs between emm types. Interestingly, the toxin
gene profile of the isolates was independent of the clinical
manifestation.
Macrophage GAS phagocytosis depends both upon emm
type and the invasiveness status of the isolate, whereas
only emm type correlates with survival
Macrophages are critical host defense cells involved directly in
bacterial clearance and also in alerting other immune system
components to invading pathogens. We questioned if all GAS
isolates showed the same behavior in terms of macrophage’s
uptake and bacterial survival. To this end, BMDMs were
incubated with each one of the 40 GAS isolates and the
phagocytosis rate of each isolate was compared by determining
the percentage of bacterial CFUs recovered after 30 min post-
antibiotics treatment relative to the initial inoculum (Fig. 1A,
Table S2). We observed that the percentage of GAS phagocytosis
varied significantly depending on the emm type and within some
emm types according to the invasiveness status. Indeed, invasive
(Inv, black symbol) emm1 and emm89 isolates were significantly
more phagocytosed than non-invasive (NInv, white symbol)
isolates of the same emm type (Fig.1A). Also, emm89 invasive
isolates were significantly more heavily phagocytosed than the
other invasive isolates (emm1 p,0.0022, emm28 p = 0.0007). In
addition, while the range in the phagocytosis rate by BMDM cells
varied substantially between emm28 invasive isolates it was limited
for emm89 and emm1 invasive isolates. Interestingly while invasive
isolates were found more prone to phagocytosis, the emm1 strains
that are considered among the most virulent because often
associated with STSS or NF were, in contrast, the less
phagocytosed.
We then tested whether survival of GAS clinical isolates in
BMDMs within a 6-hour time window varies with the emm type or
with the isolate-associated clinical manifestations (Fig. 1B, Table
S2). Survival of any given isolate decreased over time (Table S2).
In contrast to the phagocytosis results, no significant differences
were seen, within each emm-type, between invasive (black symbols)
and non-invasive (white symbols) isolates (Fig. 1B). Interestingly,
the emm89 isolates survived better than their emm1 counterparts at
T2 and T6. Noteworthy, although the percentages of survival of
the emm89 isolates are only slightly higher, the difference in
phagocytosis leads to far more emm89 bacteria surviving at all time
points (Table S2). The emm28 isolates, be they invasive or non-
invasive, showed the highest dispersion in terms of survival.
Nevertheless, emm28 isolates survived better than emm1 isolates at
T4 and T6. One emm28 strain, M28 Inv6 appeared to be less
phagocytosed and to be cleared faster than all other strains.
However, the inoculum used for this strain was one log10 lower
than with all other strains. The smaller MOI may account for this
difference.
Because added streptomycin can in some instance kill intra-
cellular bacteria, we checked that in the conditions used, this was
not the case. The experiment was carried out with the control
emm1 invasive ATCC 700294 strain using the same protocol
except that after the washing step in presence of antibiotics (T0),
either medium alone or medium supplemented with antibiotics
was added and survival was followed by determination of the CFU
counts at T0, 1 h (T1), 2 h (T2) and 4 h (T4) p.i. (Fig. 1C). The
number of the ATCC 700294 CFUs was similar at each time
point, regardless of the presence of antibiotics, indicating that
extracellular antibiotics did not kill the intracellular bacteria.
Collectively these results indicate that whereas bacterial uptake
depends on emm type and somewhat on the isolate invasiveness
status, intracellular bacteria survival does not depend on the
invasiveness status but rather on the emm type of the isolate.
GAS-Macrophage Interaction Depends on the emm Type
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The immune mediator secretion is also correlated with
GAS emm type
Since GAS induces secretion of pro-inflammatory cytokines
during the innate immune response [26], we tested whether the
profile of secreted inflammatory mediators correlated with the
GAS emm type or with the isolate-associated clinical manifestation.
We first tested whether infected BMDMs were damaged by
intracellular bacteria by measuring the ability of BMDMS infected
with the control emm1 invasive ATCC 700294 strain as well as
with three clinical isolates from our collection, M1 Ninv1, M28
Inv5 and M89 NInv2, to retain the supravital dye neutral red (Fig.
S1). emm1 strains have been described to induce macrophage
apoptosis [26]. The amount of intracellular neutral red was similar
in non-infected BMDMs and in all infected BMDMs, indicating
that the macrophages were not damaged during the course of this
experiment.
To test a putative correlation between the profile of secreted
inflammatory mediators and the bacterial characteristics, culture
supernatants of BMDMs loaded or not with GAS and of BMDMs
stimulated with LPS (10 mg/mL) were collected at different time
points and cytokine levels were measured using ELISA (Fig. 2). All
groups of isolates were able to induce the production of early
mediators IL-6 and TNF-a. Results revealed that the pro-
inflammatory mediator production levels were all dependent on
the isolate emm type.
First, the emm1 type isolates induced higher levels of IL-6
secretion by BMDMs than isolates from any other emm type
throughout the experiment. IL-6 production by GAS-loaded cells
was similar for both invasive and non-invasive isolates, except for
the emm89 isolates at T6. IL-6 levels increased approximately
three-fold and two- to three-fold in all infected BMDMs between
T2 and T4 p.i., and T4 and T6 p.i., respectively.
Secondly, the emm1 type isolates induced higher levels of TNF-a
secretion by BMDMs than isolates from any other emm type at all
time points. The secreted TNF-a levels slightly increased over time
p.i. for all isolate groups. TNF-a secretion was not significantly
different in cells loaded with invasive or non-invasive isolate except
for the emm89 infected BMDMs for which invasive isolates
triggered higher levels of TNF-a secretion as compared to non-
invasive emm89 isolates at all time points.
Analysis at the individual isolate level indicated that emm89 GAS
throughout the experiment yielded the less scattered values of all
(Fig. 2, Table S3). Isolates that elicited high-production, compared
to the mean value within their emm type, of one cytokine did not
necessarily elicit a high production of the other: there was no link
Figure 1. Phagocytosis and survival of GAS clinical isolates in BMDMs. Cells were infected with GAS as described in Material and Methods.
(A) Percentage of phagocytosis of all (black bars), invasive (black symbols) and non-invasive (white symbols) GAS strains of different emm types. The
results are expressed as the percentage of bacterial CFUs recovered after 30 min post-antibiotics treatment relative to the initial inoculum. (B)
Bacterial survival experiments were carried out as described in the Material and Methods and expressed as the percentage of phagocytosed bacteria
that survived. (C) Intracellular bacteria were not killed by extracellular antibiotics. Cells were infected with GAS as described and after washing, either
medium with antibiotics (ATB) (black) or medium alone (dash) was added to cells. The results represent the mean 6 SD of three independent
experiments, with significance levels indicated between given isolates from the same emm type or in between emm types (*p#0.05; **p#0.01; ***p#
0.005).
doi:10.1371/journal.pone.0101464.g001
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between the relative levels of IL-6 and TNF-a induced produc-
tions. No correlation existed between CFU counts and the induced
production level of IL-6 and TNF-a, with one exception, M28
Inv6 (Table S2, Table S3). This isolate, which was the only emm28
isolate to be cleared at T2, induced one of the lowest IL-6 and
TNF-a productions. Finally, one isolate, M1 NInv4, which was
not cleared, elicited a lower production, than all other emm1
isolates, of both IL-6 and TNF-a throughout the course of this
experiment.
The ability of GAS emm1 to induce IFN-b production and its
role in host protection have been recently reported [23,27]. We
thus investigated IFN-b production by BMDMs infected by the
clinical isolates from our collection (Fig. 2). As with the pro-
inflammatory cytokine production, the mean values of IFN-b
secretion elicited by invasive and non-invasive isolates within each
emm type were similar, with the exception at T6 of the emm1-
infected BMDMs, where the invasive isolates elicited the highest
production. The IFN-b production kinetics differed depending on
the emm type. The emm89 isolate-infected BMDMs had an early
production of IFN-b, which was the highest of all infected
BMDMs at T2 and which then decreased, whereas for all other
isolates the elicited production was barely detectable before T4 or
T6. From T4 onwards, the emm1 type isolates induced the highest
production.
Analysis at the individual isolate level (Fig. 2, Table S3)
indicated that the amount of IFN-b induced by each isolate,
except the emm89 isolates, increased with time. In contrast the level
of secreted IFN-b decreased with all but one of the emm89 isolates.
Again, the M28 Inv6 isolate elicited the lowest IFN-b production
throughout time.
The levels of pro-inflammatory cytokines and type I interferon
produced is clearly dependent on the isolate emm type but seldom
dependent on the invasive status of the isolates.
Discussion
The interaction between GAS and the host innate immune
response has been studied in vitro and in vivo [8,9,18,19,28,29,30,31,32]
Figure 2. GAS clinical isolates induced pro-inflammatory mediator and IFN-b secretion by infected BMDMs. Graphics represent IL-6,
TNF-a and IFN-b quantification in the cell culture supernatant at T2h (A), T4h (B) and T6h (C) after infection by the different emm type isolates. The
mean values immune mediator productions induced by all (black bars), invasive (black symbols) and non-invasive (white symbols) of isolates of each
emm type are shown. To note, the scales are different, within the IL-6 data in panel A and, within the IFN-b data in panel C. The results represent the
mean 6 SD of 3 independent experiments; with significance levels indicated between emm1 and other emm types by stars above the corresponding
black bar and within emm types by stars above a line overlapping the corresponding the black and white symbols (*p#0.05; **p#0.01; ***p#0.005).
doi:10.1371/journal.pone.0101464.g002
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but most of the time, these studies were performed with one
strain from a given emm type leading to conclusions that were
not necessarily representative and relevant of a given popula-
tion. Genomic analyses of multiple GAS strains have been
conducted to search for gene linkage and tissue tropism or
disease severity, however in vitro experiments supporting the
results have not yet been reported [7,16,17]. Our aim was thus
to compare in vitro key features of the early innate immune
response elicited by a relevant collection of GAS isolates (n = 40)
from different emm types and invasiveness status.
We first assessed whether there was a correlation between the
genotypic toxin profile and the invasiveness status of the isolates.
The toxin profile showed high conservation within each emm type
and variation between emm types and no correlation was found
with the isolate invasiveness status. Similar results were obtained
while studying the presence of 9 and 11 superantigens and 11
superantigens and different alleles of speA, in 87, 107 and 291
isolates, respectively [16,17,25]. However, in that carried out on
291 clinical isolates (194 colonization and 97 invasive isolates), the
speA1-speA3 alleles, as well as the speJ gene were found more
frequently in invasive than colonization isolates [16]. Our study
shows that neither speA allele nor the presence of speJ could be
linked to the clinical manifestation. It is therefore likely that the
differences observed might be due to the expression level of
superantigens which can be modulated by bacterial or human host
determinants.
The role of macrophages in GAS diseases may be dual as they
can kill the bacteria but they can also be used as a Trojan horse in
which bacteria survive [19,33]. The first step benefits the host
while in contrast the second benefits the bacterium. Herein we
report that invasive isolates from emm type emm89, were more
phagocytosed than their non-invasive counterparts. emm1 invasive
isolates have been shown to persist and even multiply in the
macrophages. When coupled to a more efficient phagocytosis,
these features might contribute to the increased invasion capacity
of some emm1 isolates. The invasive emm89 isolates which were the
most successfully phagocytosed isolates in this study also survived
intracellularly slightly better than others, suggesting that they
might hijack the macrophages to their own benefit, in particular
for persistence. It would be interesting to study whether emm89
isolates elicit particularly persistent or recurring GAS infections
while our observation suggests that they could be responsible for
antibiotic treatment failure observed in some GAS infections.
Finally, emm28 isolates, that are associated with puerperal fever,
are also able to survive more than emm1 isolates in the macrophage
[6]. Survival or death of intracellular bacteria may be a
consequence of the entry pathway [19]. The entry pathway,
permitting GAS survival, and bacterial factors promoting it are
currently unknown. Among bacterial factors involved in survival
are the M1 protein shown to impair proper fusion of the
phagosome with lysosomes and SLO, together with NAD-
glyohydrolase, reported to protect GAS from xenophagic killing
[14]. Since the emm89 isolates, on the whole, survived better than
isolates from the emm1 emm type, it would be interesting to test
whether the M89 protein or the associated M-like proteins
interfere with the host phagosomal-lysosomal pathway. Interest-
ingly, the emm89 isolates induced a more rapid secretion of IFN-b
as well as a weaker IL-6 and TNF-a by macrophages than isolates
from the other emm types. One hypothesis to account for this
difference is that the M89 protein or the M-like proteins could, like
M1 but more efficiently, induce a suppression of inflammatory
signals. Alternatively and not exclusively, the early IFN-b secretion
may control the pro-inflammatory response, limiting it. The
reason for the decrease in IFN-b production by the emm89-infected
BMDMs as soon as T4 is currently unknown.
In our experiments, the survival property of the isolates was not
linked to the invasive status of the isolates. However, in vivo, the
recruitment of other phagocytic cells may interfere with the tissue
invasion properties of the isolate. Since qualitative and quantita-
tive differences in the cytokine secreted between isolates have been
detected in our in vitro assays, these are likely to modulate
phagocytic cell as well as non-phagocytic cell recruitment and
functions and therefore to contribute to the invasion phenotype.
Finally, studies have demonstrated that the same streptococcal
strain could cause infections with diverse severity in different
individuals, emphasizing the influence of the host genetic factors,
most likely involved in the defense responses, on the outcome of
infections [34].
In our study we observed that GAS had different pathogenesis
mechanisms depending on the emm type. The emm1 isolates were
able to induce an early overwhelming pro-inflammatory cytokines
production. In vivo, this may drive the host system in an
inflammatory loop that would be damaging for the host.
In the case of emm89 isolates, that were phagocytized and
survived longer than any other emm type isolates, the mechanism
might involve pro-inflammatory signals but at later time points,
and the initial interferon type I production may interfere with the
recruitment of other innate immune cells including neutrophils, as
already reported [27]. Of note, the isolates that have longer-term
intracellular survival potential have higher chances to avoid the
antibiotics therapeutics that are commonly prescribed for the
treatment of GAS infections.
With the goal of assaying the existence of differences depending
on the invasiveness status or on the genotype of the strains, the
experiments were carried out with murine BMDMs. Although
using mouse macrophages for studying this human pathogen has
some limitations, this model has previously been successfully used
and has the advantage that the cells are not donor dependent [16].
Furthermore, the mouse proinflammatory response mimics that
observed in patients with severe invasive infections. Plasma
proteins such as fibrinogen could also be added to better mimic
the in vivo situation. Our study has enabled us, in addition to draw
conclusion as to the importance of the emm type on all innate
immunity events tested, to point out to strains that are
representative of all strains from their groups and others which
are atypical. These strains, in limited number, may now be
employed to further study the mechanisms involved in the host-
pathogen interaction using human cells.
In conclusion, for all aspects of the innate immune response
analyzed, the emm type has more influence than the invasiveness
status of the isolate.
Supporting Information
Figure S1 BMDMS viability is not altered during the
experiments. BMDMS viability is not altered during the
experiments. The BMDMs were infected using MOI = 100 for
30 min at 37uC; afterwards cells were washed and incubated with
medium plus antibiotics. At each time point the neutral red
medium was added, and after 2 h incubation at 37uC the plates
were washed and the dye was extracted with acidified ethanol
solution. A decrease in color was quantified at 540 nm. The
percentage of viable cells was calculated as follows, the mean value
from wells without cells was subtracted from the other wells, and
the values of treated cultures were referred to control uninfected
cultures. Values represent the mean6 SD of percentage of neutral
red uptake at different time points of two wells per treatment and
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correspond to one representative experiment of three independent
experiments.
(TIF)
Table S1 Characteristics of GAS isolates used in this
study.
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Table S2 Phagocytosis and intracellular survival.
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Table S3 Innate immune modulators production in the
BMDMs cultures.
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